Title:
縮環キナゾリン誘導体及びその使用
Document Type and Number:
Japanese Patent JP2013526590
Kind Code:
A
Abstract:
Fused quinazoline derivatives and uses thereof as protein tyrosine kinase inhibitors and aurora kinase inhibitors are disclosed. Said protein tyrosine kinase inhibitors and aurora kinase inhibitors can be used in treating cancers, leukaemia and the diseases relevant to differentiation and proliferation. Said protein tyrosine kinase and aurora kinase dual inhibitors are the compounds represented by the following general formula or salts thereof.
More Like This:
Inventors:
Lijanki
Zan Zui Shu
Pen
Zan Kinway
Zan Zui Shu
Pen
Zan Kinway
Application Number:
JP2013511520A
Publication Date:
June 24, 2013
Filing Date:
May 20, 2011
Export Citation:
Assignee:
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
International Classes:
C07D487/04; A61K31/519; A61K31/5377; A61P35/00; A61P35/02; A61P43/00
Attorney, Agent or Firm:
Yoshiyuki Kaji
Makoto Suhara
Makoto Suhara